Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Reassessing the risk-modifying effects of novel antidiabetic agents on asthma-COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials
EClinicalMedicine, 2026;97:104026
Orforglipron for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity or overweight: Study design and baseline characteristics of ATTAIN-OSA, a phase 3 trial
Contemporary clinical trials communications, 2026;52:101660
Case Report: Dramatic metabolic improvement with tirzepatide in a patient with acquired partial lipodystrophy following hematopoietic stem cell transplantation
Frontiers in endocrinology, 2026;17:1868458
Functional segregation of body-brain signals in the area postrema
bioRxiv : the preprint server for biology, 2026
Insufficient exclusion of infectious and biofilm-related complications in reported tirzepatide-associated filler nodules
JAAD case reports, 2026;75:216
A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026
JAMA, 2026
Real-world experience of semaglutide 2.4 mg in the US: a retrospective analysis of profiles, satisfaction, and treatment patterns in people with obesity and overweight
Current medical research and opinion, 2026;:1-12
Cardiovascular outcomes of semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
Diabetology & metabolic syndrome, 2026
Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics
Chemistry (Weinheim an der Bergstrasse, Germany), 2026;:e71280
Differential impact of pre-operative tirzepatide compared to glucagon-like-peptide-1 single receptor agonists on outcomes of spinal fusion surgery in obese patients
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026
Semaglutide exerts anti-pulmonary fibrosis effects by inhibiting cellular senescence through activation of the Sirt1/HSF1/HSPs pathway
Biochemical pharmacology, 2026;:118172
Negative effects of semaglutide on bone in obese mice
Cell reports. Medicine, 2026;:102875
Association Between GLP-1RAs and Postoperative Complications Following Operative Ankle Fracture Fixation: A Retrospective Cohort Study
Foot & ankle orthopaedics, 2026;11(2):24730114261453350
Psychiatric Safety Signals of GLP-1 Receptor Agonists: A FAERS-Based Pharmacovigilance Study with Explainable Machine Learning
Pharmaceuticals (Basel, Switzerland), 2026;19(6)
Insulin Resistance as a Systemic Metabolic Risk State for Cancer: Mechanisms, Biomarkers, and Prevention
International journal of molecular sciences, 2026;27(12)
Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists
Spine, 2026
Obstetrical and medical outcomes following GLP-1 receptor agonist exposure in pregnancy: a case series
Case reports in women's health, 2026;51:e00831
Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework
Obesity pillars, 2026;19:100290
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus: a network meta-analysis based on clinical trials
Frontiers in pharmacology, 2026;17:1846714
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Frontiers in endocrinology, 2026;17:1822475